Pruritic papular eruption of the acquired immunodeficiency syndrome: a clinicopathologic study. 1991

O Hevia, and F Jimenez-Acosta, and P I Ceballos, and E W Gould, and N S Penneys
Department of Dermatology and Cutaneous Surgery, University of Miami.

The pruritic papular eruption of the acquired immunodeficiency syndrome is characterized by generalized, pruritic, skin-colored papules and nodules. Chronic lesions are excoriated and hyperpigmented. The eruption and pruritus typically wax and wane and are resistant to oral antihistamine and topical steroid therapy. The characteristic histologic features are (1) superficial and mid dermal perivascular and perifollicular mononuclear cell infiltrate with numerous eosinophils and (2) follicular damage of varying degrees. When compared with control subjects, these patients did not demonstrate any significant difference in laboratory or demographic data.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D008297 Male Males
D011537 Pruritus An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief. Itching,Pruritis
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003872 Dermatitis Any inflammation of the skin. Dermatitides
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

O Hevia, and F Jimenez-Acosta, and P I Ceballos, and E W Gould, and N S Penneys
May 1994, Acta dermato-venereologica,
O Hevia, and F Jimenez-Acosta, and P I Ceballos, and E W Gould, and N S Penneys
March 1992, Journal of the American Academy of Dermatology,
O Hevia, and F Jimenez-Acosta, and P I Ceballos, and E W Gould, and N S Penneys
November 2000, International journal of dermatology,
O Hevia, and F Jimenez-Acosta, and P I Ceballos, and E W Gould, and N S Penneys
August 1989, Journal of the American Academy of Dermatology,
O Hevia, and F Jimenez-Acosta, and P I Ceballos, and E W Gould, and N S Penneys
November 1991, International journal of dermatology,
O Hevia, and F Jimenez-Acosta, and P I Ceballos, and E W Gould, and N S Penneys
February 2023, JAAD case reports,
O Hevia, and F Jimenez-Acosta, and P I Ceballos, and E W Gould, and N S Penneys
April 1990, Archives of dermatology,
O Hevia, and F Jimenez-Acosta, and P I Ceballos, and E W Gould, and N S Penneys
November 1991, Journal of the American Academy of Dermatology,
O Hevia, and F Jimenez-Acosta, and P I Ceballos, and E W Gould, and N S Penneys
July 1989, Archives of dermatology,
O Hevia, and F Jimenez-Acosta, and P I Ceballos, and E W Gould, and N S Penneys
October 2006, Dermatologic clinics,
Copied contents to your clipboard!